AbbVie appoints Robert Michael as Vice Chairman and President; Scott Reents as CFO

AbbVie Inc.

Robert A. Michael, previously CFO, named Vice Chairman and President effective June 23, 2022.
Scott T. Reents, formerly VP Tax and Treasury, appointed Senior Vice President and CFO effective June 23, 2022.
Both appointments are internal promotions; Michael joined Abbott in 1993, Reents in 2008.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Robert A. Michael

Vice Chairman and President

ABBV · AbbVie Inc.

Effective: 2022-06-23
Successor: Scott T. Reents
Filed: June 28, 2022, 7:59 PM ET

Robert A. Michael, 51, has been appointed Vice Chairman and President, effective June 23, 2022.

Appointed

Scott T. Reents

Senior Vice President, Chief Financial Officer

ABBV · AbbVie Inc.

Effective: 2022-06-23
Filed: June 28, 2022, 7:59 PM ET

Scott T. Reents, 55, has been appointed Senior Vice President, Chief Financial Officer, effective June 23, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Robert A. Michael was appointed as Vice Chairman and President at AbbVie Inc..

Action: appointed
Role: Vice Chairman and President

Exact text from the filing

Robert A. Michael, 51, has been appointed Vice Chairman and President, effective June 23, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Scott T. Reents was appointed as Senior Vice President, Chief Financial Officer at AbbVie Inc..

Action: appointed
Role: Senior Vice President, Chief Financial Officer

Exact text from the filing

Scott T. Reents, 55, has been appointed Senior Vice President, Chief Financial Officer, effective June 23, 2022.

View on SEC.gov

AbbVie Inc. filing history →

Source: SEC EDGAR

accession 0001104659-22-075039

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.